Study Finds on MSN
How Egg Shape Coordinates the Cascade of Early Development
Research shows how the curved shape of a zebrafish egg sets cell division timing, gene activation, and early cell fate ...
With copper-blue blood prized by modern medicine and a body plan older than dinosaurs, the horseshoe crab reveals how ancient ...
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...
10don MSN
Biology-inspired brain model matches animal learning and reveals overlooked neuron activity
A new computational model of the brain based closely on its biology and physiology has not only learned a simple visual ...
Chinese scientists clone monkeys using the same technique that produced Dolly the sheep two decades ago, breaking a technical barrier that could open the door to copying humans.
Breakthrough in intractable intestinal disease treatment using xenogeneic-free intestinal stem cells
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
2don MSN
Cracking sleep's evolutionary code: Neuron protection traced back to jellyfish and sea anemones
A new study from Bar-Ilan University shows that one of sleep's core functions originated hundreds of millions of years ago in ...
Medical experiments on research dogs could be phased out soon — a change that’s based as much on science as ethics.
AZ Animals US on MSN
Why Do Animals Age at Different Rates? The Science Behind Lifespan Variation
Find out which animals live the longest and what clues this gives us for potentially slowing down human aging.
According to new research recently published in the journal Nature Communications, the Greenland shark retained its visual ...
Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results